Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of Illumina, Inc. (“Illumina” or the “Company”) (Nasdaq: ILMN) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s receipt of a proposal from Roche to acquire the Company for approximately $5.7 billion in cash (the “Proposal”).

The investigation concerns the board of directors’ process for consideration of the proposed transaction, whether Illumina is acting in its shareholders’ best interests by refusing to enter into negotiations with Roche, and whether the proposed consideration to be paid to Illumina shareholders would be fair and adequate.

The Proposal contemplates Roche’s acquisition of all of the outstanding shares of common stock of Illumina for $44.50 per share in cash.  Moreover, Roche stated that although it “continues to prefer a negotiated transaction with Illumina, Roche intends to promptly commence a tender offer to purchase all of the outstanding shares of common stock of Illumina for $44.50 per share in cash.  Additionally, in view of your board’s response, we plan to nominate a slate of directors and make certain other proposals for the consideration of shareholders at Illumina’s 2012 annual meeting which, if adopted, would result in Roche-nominated directors comprising a majority of your board.”

If you own the common stock of Talbots and purchased your shares before January 24, 2012, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky, Esquire or Noah R. Wortman, Case Development Director, of Rigrodsky & Long, P.A., 919 N. Market Street, Suite 980, Wilmington, Delaware, 19801, by telephone at (888) 969-4242, or by e-mail to info@rigrodskylong.com.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.